Read the original post: Faron Pharmaceuticals Notice of Half-Year Financial Results
Read the original post: Faron Pharmaceuticals Notice of Half-Year Financial Results
Go here to see the original: Bioventus to Present at the Canaccord Genuity 43rd Annual Global Growth Conference
Continue reading here: Universe Pharmaceuticals INC Announces Receipt of Nasdaq Notification Regarding Minimum Market Value of Publicly Held Shares
Read the original: Better Choice Company Makes Its Interim CFO Permanent
Read more here: ImPact Biotech receives FDA Clearance for Padeliporfin VTP Phase 1 Clinical Program in Peripheral Lung Cancer
See original here: Rani Therapeutics to Participate in August Investor Conferences
Read more from the original source: NANOBIOTIX to Host Extraordinary General Meeting of Shareholders on September 1st, 2023
Originally posted here: Aceragen, Inc. to Delist from The Nasdaq Stock Market
View original post here: XORTX Appoints Chief Financial Officer
Excerpt from: Vivoryon Therapeutics N.V. Announces Proposed Appointment of Dr. Frank Weber as Chief Executive Officer
Recent Comments